Modeling of 24-hour glucose and insulin profiles of patients with type 2 diabetes
- PMID: 20220046
- DOI: 10.1177/0091270010362536
Modeling of 24-hour glucose and insulin profiles of patients with type 2 diabetes
Abstract
A model able to simultaneously characterize and simulate 24-hour glucose and insulin profiles following multiple meal tests was developed, extending an integrated glucose-insulin model for oral glucose tolerance tests that was previously published. The analysis was based on glucose and insulin measurements from 59 placebo-treated patients with type 2 diabetes. Circadian variations in glucose homeostasis were assessed on relevant parameters based on literature review. They were best described by a nighttime dip in insulin secretion between approximately 9 p.m. and 5 a.m. using a modulator function. The integrated glucose-insulin model has thus been shown to be applicable to real-life situations determined by multiple meals over the course of a day. This provides the basis for the analysis and simulation of long-term glucose and insulin data. The model may also prove useful for understanding antidiabetic drug actions and requirements in the context of circadian changes in glucose-insulin regulation.
Similar articles
-
Modeling of 24-hour glucose and insulin profiles in patients with type 2 diabetes mellitus treated with biphasic insulin aspart.J Clin Pharmacol. 2014 Jul;54(7):809-17. doi: 10.1002/jcph.270. Epub 2014 Mar 11. J Clin Pharmacol. 2014. PMID: 24446385 Clinical Trial.
-
Hormonal and glycaemic responses to serial meals in newly diagnosed non insulin dependent diabetic patients.Diabete Metab. 1989 Jan-Feb;15(1):1-4. Diabete Metab. 1989. PMID: 2656328
-
Physiologic modeling of the intravenous glucose tolerance test in type 2 diabetes: a new approach to the insulin compartment.Metabolism. 2001 May;50(5):512-9. doi: 10.1053/meta.2001.21029. Metabolism. 2001. PMID: 11319711 Clinical Trial.
-
[Circadian variation in blood glucose levels, in glucose tolerance and in plasma immunoreactive insulin levels].Acta Diabetol Lat. 1972 Mar-Apr;9(2):263-75. doi: 10.1007/BF01564551. Acta Diabetol Lat. 1972. PMID: 4564841 Review. Multiple languages. No abstract available.
-
Modeling approaches to type 2 diabetes.Diabetes Technol Ther. 2004 Feb;6(1):39-47. doi: 10.1089/152091504322783396. Diabetes Technol Ther. 2004. PMID: 15000768 Review.
Cited by
-
Toward Better Understanding of Insulin Therapy by Translation of a PK-PD Model to Visualize Insulin and Glucose Action Profiles.J Clin Pharmacol. 2019 Feb;59(2):258-270. doi: 10.1002/jcph.1321. Epub 2018 Oct 19. J Clin Pharmacol. 2019. PMID: 30339268 Free PMC article.
-
Study Design Selection in Early Clinical Anti-Hyperglycemic Drug Development: A Simulation Study of Glucose Tolerance Tests.CPT Pharmacometrics Syst Pharmacol. 2018 Jul;7(7):432-441. doi: 10.1002/psp4.12302. Epub 2018 May 6. CPT Pharmacometrics Syst Pharmacol. 2018. PMID: 29732710 Free PMC article.
-
Impact of Obesity on Postprandial Triglyceride Contribution to Glucose Homeostasis, Assessed with a Semimechanistic Model.Clin Pharmacol Ther. 2022 Jul;112(1):112-124. doi: 10.1002/cpt.2604. Epub 2022 May 15. Clin Pharmacol Ther. 2022. PMID: 35388464 Free PMC article.
-
Mathematical Modeling for the Physiological and Clinical Investigation of Glucose Homeostasis and Diabetes.Front Physiol. 2020 Nov 25;11:575789. doi: 10.3389/fphys.2020.575789. eCollection 2020. Front Physiol. 2020. PMID: 33324238 Free PMC article. Review.
-
Dose selection using a semi-mechanistic integrated glucose-insulin-glucagon model: designing phase 2 trials for a novel oral glucokinase activator.J Pharmacokinet Pharmacodyn. 2013 Feb;40(1):53-65. doi: 10.1007/s10928-012-9286-9. Epub 2012 Dec 22. J Pharmacokinet Pharmacodyn. 2013. PMID: 23263772 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical